Drug details
Mydayis (mixed salts of a single-entity amphetamine product capsules)
type of Stimulants, ADHD Agents
Mydayis (mixed salts of a single-entity amphetamine product) extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.
This drug may have the following side effects:
- chest pain,
- nausea,
- headache,
- sweating,
- dizziness,
- vomiting,
- diarrhea,
- weakness,
- cough,
- hoarseness,
- sore throat,
- itching,
- joint pain,
- loss of appetite,
- fever,
- chills,
- runny nose,
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- confusion,
- fainting,
- seizures,
- muscle pain,
- trouble sleeping,
- dark urine,
- double vision,
- hallucinations,
- muscle cramps,
- unusual tiredness,
- shivering,
- loss of consciousness,
- blood in your urine,
- difficulty swallowing,
- trouble speaking,
- bladder pain,
- painful or burning when urinating,
- fast, pounding, or irregular heartbeat,
- frequent urge to urinate,
- lower back or side pain,
- general feeling of unwellness,
- blistering, peeling, or loosening of the skin,
- inability to move the arms, legs, or facial muscles,
- loss of bladder control,
- muscle spasms or jerking of the arms or legs,
- pain or discomfort in the arms, jaw, back, or neck,
- red skin lesion with a purple center,
- red, irritated eyes,
- slow speech,
- white spots in the mouth or on the lips,
- swelling of the feet or lower legs, and
- uncontrolled vocal outbursts
The following drugs are related to Mydayis, either as a replacement or used together:
- Xelstrym (dextroamphetamine)